Hypoglossal Nerve Stimulation (HNS) for OSA with BMI < 32 and Specific Airway Collapse Pattern
Hypoglossal Nerve Stimulation (HNS) has emerged as an important treatment option for patients with obstructive sleep apnea (OSA) who are unable to tolerate continuous positive airway pressure (CPAP). While CPAP remains the first-line therapy, a significant proportion of individuals struggle with long-term adherence due to discomfort, aerophagia, claustrophobia, or difficulties maintaining a proper seal.
Understanding the importance of BMI and collapse pattern is central to the success of HNS. Excess adipose tissue in the neck and tongue base can overwhelm the capacity of the device to maintain airway patency.
Symptoms & Causes
Patients eligible for HNS often present with symptoms typical of moderate to severe OSA, including loud snoring, witnessed apneas, gasping awakenings, nocturnal choking, and fragmented sleep.
The underlying cause of OSA in patients with BMI < 32 and favorable collapse patterns is typically related to anatomic and neuromuscular factors rather than extensive adiposity.
Diagnosis & Tests
A thorough diagnostic process is essential before considering HNS. Patients are first evaluated through polysomnography, which confirms the presence and severity of OSA.
One of the most important components of the diagnostic workup is the body mass index measurement. A BMI less than 32 is a major eligibility criterion because patients with higher BMI tend to have excess pharyngeal fat contributing to airway collapse that cannot be adequately countered by tongue protrusion alone.
Drug-induced sleep endoscopy (DISE) plays a crucial role in determining airway collapse patterns. During DISE, clinicians observe real-time dynamic airway behavior under sedation that mimics sleep physiology.
Mechanism of HNS for OSA
Hypoglossal nerve stimulation works by delivering synchronized electrical impulses to branches of the hypoglossal nerve that control tongue protrusion. The device senses the patient’s breathing cycle through an implanted sensor that detects intrathoracic pressure changes.
For patients with BMI under 32 and favorable collapse patterns, this mechanism is highly effective. Because the airway anatomy is not excessively burdened by adipose tissue, the stimulated muscular movement is sufficient to maintain patency.
Treatment Process
Treatment begins with a detailed evaluation by a sleep specialist and an HNS-credentialed surgeon.
Following surgery, there is a healing period of several weeks before activation. After activation, titration occurs over several months.
Trial Phase (if included)
Hypoglossal nerve stimulation does not traditionally involve an externalized trial phase like some neuromodulation therapies (e.g., spinal cord stimulation).
Surgery & Programming
HNS implantation is performed under general anesthesia through three small incisions: one to place the stimulation cuff around the hypoglossal nerve, one to introduce the respiratory sensor over intercostal muscles, and one to house the implantable pulse generator.
Device activation occurs approximately one month after surgery to allow adequate healing. Programming sessions begin with low-level stimulation and gradually increase as tolerated.
Risks & Complications
Although generally well tolerated, HNS carries potential risks. Surgical complications may include infection, hematoma, nerve irritation, or discomfort at the incision sites.
Non-surgical side effects after activation may include tongue discomfort, muscle twitching, difficulty swallowing, dry mouth, or arousals caused by excessive stimulation.
Outcomes & Success Rates
Patients with BMI < 32 and the appropriate collapse pattern consistently demonstrate the highest success rates with HNS. Clinical trials such as the STAR trial and subsequent real-world registries document significant reductions in AHI, oxygen desaturation index, and snoring intensity.
Success is defined not only by improvement in AHI but also by functional gains in sleep quality, alertness, cognition, and quality of life. Many patients report reduced morning headaches, improved mood, and elimination of bed-partner disturbances. Outcomes tend to remain stable over years, with ongoing device function and low rates of explantation.
Prevention & Prognosis
For individuals who meet BMI and collapse-pattern criteria, the prognosis with HNS is excellent. Weight stability is important; significant weight gain can reduce effectiveness by increasing pharyngeal fat burden and altering collapse dynamics.
Prevention of disease progression focuses on maintaining healthy weight, managing nasal congestion or allergies, and addressing contributing comorbidities such as hypothyroidism or hypothesized neuromuscular deficits.